Novartis announced the start of GALIANT, a significant clinical trial set to involve more than 7,500 people in the United States comparing the investigational oral type 2 diabetes medication Galvus? (vildagliptin) with commonly prescribed anti-diabetic oral medicines called thiazolidinediones (TZDs).
The U.S. Food and Drug Administration (FDA) is alerting the public to counterfeit blood glucose test strips being sold in the United States for use with various models of LifeScan, Inc., One Touch Brand Blood Glucose Monitors used by people with diabetes to measure their blood glucose.
The National Institutes of Health (NIH) has released a long range plan that will help to guide research in type 1 diabetes for the next decade. Advances and Emerging Opportunities in Type 1 Diabetes Research: A Strategic Plan identifies goals and objectives to exploit recent scientific advances in combating this autoimmune form of diabetes.
Exercise can help people with large waistlines reduce their risk of developing type 2 diabetes, Finnish researchers said. Type 2 diabetes, the more common form of the illness caused by an inability to make or properly use insulin, is linked to being overweight or obese.
High-calorie, low-fiber diets can promote hormonal imbalances that lead children to overeat, one researcher warns.
In elderly patients with type 2 or non-insulin dependent diabetes, treatment with the short-acting drug repaglinide (NovoNorm) may be safer than that with the longer-acting drug, glibenclamide (glyburide), Italian researchers report.
Researchers have revealed that drinking coffee, especially the decaffeinated kind, seems to offer protection against type 2 diabetes.
The link between coffee and diabetes risk appears to be consistent across different ages and body weights; in addition, most research has found that the more coffee an individual generally drinks, the lower his or her risk for diabetes.
Performing transcendental meditation, a relaxation technique derived from the ancient Vedic tradition in India, may improve cardiac risk factor in people with coronary heart disease, says a study.
A new study has found that elevated levels of a molecule called RBP4 (retinol binding protein 4) can foretell early stages in the development of insulin resistance, a major cause of type-II diabetes as well as cardiovascular disease.
Meditation has always shown to have calming effect on the body and the soul, but the researchers now have uncovered yet another benefit of transcendental meditation, that it may reduce cardiac risk factors in patients with coronary heart disease.